Search research articles
Contact Us
Filters
Showing results (111-120 of 145) with videos related to
Page
of 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis
, Koji Oba, Xavier Paoletti, et al.
Plos One
|
November 7, 2014
Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts
Ludmilla de Plater, Anne Vincent-Salomon, Frédérique Berger, et al.
Bulletin Du Cancer
|
January 23, 2015
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB]
Monia Ezzalfani, Audrey Dugué, Caroline Mollevi, et al.
Cancers
|
March 29, 2023
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
Eleni Karamouza, Rosalind M Glasspool, Caroline Kelly, et al.
Future Oncology (London, England)
|
May 5, 2025
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients
François Cherifi, Isabelle Ray-Coquard, Maria Jesus Rubio, et al.
Targeted Oncology
|
November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial
Christophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Journal of the National Cancer Institute
|
October 11, 2013
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis
Koji Oba, Xavier Paoletti, Steven Alberts, et al.
Neuro-Oncology
|
October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
Pauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis
Pauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 145) with videos related to
Sort By:
Page
of 15
European Journal of Cancer (Oxford, England : 1990)
|
January 29, 2013
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis
, Koji Oba, Xavier Paoletti, et al.
Plos One
|
November 7, 2014
Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts
Ludmilla de Plater, Anne Vincent-Salomon, Frédérique Berger, et al.
Bulletin Du Cancer
|
January 23, 2015
[The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB]
Monia Ezzalfani, Audrey Dugué, Caroline Mollevi, et al.
Cancers
|
March 29, 2023
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data
Eleni Karamouza, Rosalind M Glasspool, Caroline Kelly, et al.
Future Oncology (London, England)
|
May 5, 2025
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients
François Cherifi, Isabelle Ray-Coquard, Maria Jesus Rubio, et al.
Targeted Oncology
|
November 20, 2012
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial
Christophe Le Tourneau, Maud Kamal, Olivier Trédan, et al.
Journal of the National Cancer Institute
|
October 11, 2013
Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis
Koji Oba, Xavier Paoletti, Steven Alberts, et al.
Neuro-Oncology
|
October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors
Birgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 5, 2023
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis
Pauline Corbaux, Benoit You, Rosalind M Glasspool, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 19, 2025
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis
Pauline Corbaux, Benoit You, Tatsuo Kagimura, et al.
Page
of 15